Intuitive Surgical Maintains Da Vinci Procedure Growth Outlook for 2026
Intuitive Surgical (NASDAQ:ISRG) reaffirmed its long-term growth outlook of a 13.5%-15.5% annual increase in da Vinci procedures through 2026, while also outlining an expected non-GAAP gross margin range of 68%-69%. The company reported strong Q2 performance with total procedure volume up 16%, driven by 15% growth in da Vinci and a significant 36% rise in Ion procedures.
Tickers: $ISRG
Topics: Earnings Medical Devices Robotics Surgery